|
MRI News Service:
'Safety' p7 |
|
|
|
 |
 | | | ''Medtronic Inc. has received European approval to market a pacemaker that can be used with MRI machines. Patients with pacemakers are now unable to undergo magnetic-imaging resonance scans due to safety concerns. MRI scans have the potential to cause ...' | | Monday, 17 November 2008 by www.bizjournals.com |
|
|
|
| | | ''Leucadia, CA, November 15, 2008 --(PR.com)-- The Facility Guidelines Institute, which publishes the most often used building code for hospitals and health care providers in the U.S., has made the draft language of their next update available for public ...' | | | Saturday, 15 November 2008 by www.pr.com | |
|
|
|
| | | ''The world's most powerful medical magnetic resonance imaging machine, the 9.4 Tesla at the University of Illinois at Chicago, has successfully completed safety trials and may soon offer physicians a real-time view of biological processes in the human ...' | | | Tuesday, 4 December 2007 by www.eurekalert.org | |
|
|
|
| | | ''TEL AVIV, Israel and WASHINGTON DC, October 23 /PRNewswire-FirstCall/ -- TopSpin Medical (TASE: TOPMD) announced today that the 30-day results from the multicenter prospective study of the TopSpin Intravascular Magnetic Resonance Imaging System During ...' | | | Tuesday, 23 October 2007 by www.biospace.com | |
|
|
|
| | | ''PITTSFORD, NY, AUGUST 9, 2007 – Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced that the Company has entered into a definitive agreement with Medtronic, Inc., (NYSE: MDT) to acquire ...' | | | Thursday, 9 August 2007 by www.biophan.com | |
|
|
|
| | | ''MINNEAPOLIS - Feb. 9, 2007 - Medtronic, Inc. (NYSE: MDT) today announced the start of an international clinical study to confirm the safety and efficacy of the Medtronic EnRhythm® MRI SureScan- pacing system, the first-ever pacemaker system to be ...' | | | Friday, 9 February 2007 by wwwp.medtronic.com | |
|
|
|
| | | ''Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, published a report written with the U.S. Food and Drug Administration (FDA) entitled: Biophan Technologies CRADA Workshop on the Safe Use of ...' | | | Monday, 8 January 2007 by findarticles.com | |
|
|
|
| | | ''Rheumatoid arthritis (RA) is a complex and destructive inflammatory disease. Despite recent impressive advances in disease-modifying antirheumatic drugs and biologic therapies, treatment is not always effective and still has many safety ramifications. ...' | | | Wednesday, 29 March 2006 by www.eurekalert.org | |
|
|
|
| | | ''Hepatic steatosis, or fatty liver, is commonly observed duringthe animal phase of drug safety studies. A noninvasive threedimensional(3D) three-point Dixon method was used to quantitativelyevaluate the fatty livers of rats induced by an ...' | | | 2004 by www.civm.duhs.duke.edu | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
There are risks and costs to a program of action. But they are far less than
the long-range risks and costs of comfortable inaction.
- John F. Kennedy |
|
|
News
top
